Cargando…
Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
Autores principales: | Lemay, Sarah‐Eve, Grobs, Yann, Boucherat, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111511/ https://www.ncbi.nlm.nih.gov/pubmed/36892086 http://dx.doi.org/10.1161/JAHA.123.029503 |
Ejemplares similares
-
Reverse Reaction of Nicotinamide Nucleotide Transhydrogenase Promotes ROS Production and Contributes to Right Ventricular Failure
por: Lemay, Sarah-Eve, et al.
Publicado: (2022) -
PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022) -
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension
por: Grobs, Yann, et al.
Publicado: (2021) -
Human Resistin Induces Cardiac Dysfunction in Pulmonary Hypertension
por: Lin, Qing, et al.
Publicado: (2023) -
Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
por: Lemay, Sarah-Eve, et al.
Publicado: (2021)